B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE

B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab

R. John Looney, Jennifer H. Anolik, Debbie Campbell et al. · Arthritis & Rheumatism · 2004 · 777 citations

Life Sciences, Immunology, Pharmacotherapy +16

An open study of B lymphocyte depletion in systemic lupus erythematosus

Maria Leandro, Jonathan Edwards, Geraldine Cambridge et al. · Arthritis & Rheumatism · 2002 · 579 citations

Life Sciences, Immunology, Pharmacotherapy +17

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

Kazuyoshi Saito, Daisuke Kawabata, Shingo Nakayamada et al. · Annals of the Rheumatic Diseases · 2006 · 345 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy

Jennifer H. Anolik, Jennifer Barnard, Teresa Owen et al. · Arthritis & Rheumatism · 2007 · 335 citations

Life Sciences, Immunology, Pathology +17

A retrospective seven‐year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients

Tiange Lu, Kristine Ng, Geraldine Cambridge et al. · Arthritis Care & Research · 2009 · 274 citations

Life Sciences, Immunology, Pharmacotherapy +17